Quantum Pharma PLC TR-1: Notification Of Major Interest In Shares (9671G)
November 25 2015 - 10:00AM
UK Regulatory
TIDMQP. TIDMAV.
RNS Number : 9671G
Quantum Pharma PLC
25 November 2015
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
-----------------------------------------------------------------------------------------------------------
1. Identity of the issuer or Quantum Pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------------- ----------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-----------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
-------------------------------------------------------------------- -------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
-------------------------------------------------------------------- -------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
-------------------------------------------------------------------- -------------------------------------
An event changing the breakdown of voting rights
-------------------------------------------------------------------- -------------------------------------
Other (please
specify):
----------------------------------------------------------- ------- -------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
------------------------------------------------------------- --------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
BNY Norwich Union Nominees
Limited 576,036*
Chase (GA Group) Nominees
Limited 8,086,177*
*denotes direct interest
Chase Nominees Limited 248,348
------------------------------------------------------------- --------------------------------------------
5. Date of the transaction 23 November 2015
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------------- --------------------------------------------
6. Date on which issuer 24 November 2015
notified:
------------------------------------------------------------- --------------------------------------------
7. Threshold(s) that is/are 7% to 6% Change at Direct
crossed or Interest Level
reached: (vi, vii)
------------------------------------------------------------- --------------------------------------------
8. Notified details:
-----------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
-----------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------------- ------------------------------- -----------------------------------------------------
Number Number Number Number of % of voting
of of of voting rights (x)
Shares Voting shares rights
Rights
------------------- ------------------- ---------- ---------- --------------------- ------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------------- ------------------- ---------- ---------- ---------- --------- ------- ---------
Ordinary
Shares
GB00BRTL8Q42 9,190,155 9,190,155 8,910,561 8,662,213 248,348 6.93% 0.20%
------------------- ---------- ---------- ---------- --------- ------- ---------
B: Qualifying Financial Instruments
-----------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------- ------------------- ---------------------- --------------------- ------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
8,910,561 7.13%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited, with the following
chain of controlled undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Proxy Voting:
-----------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
--------------------------------------------- ------------------------------
11. Number of voting rights proxy
holder will cease
to hold:
--------------------------------------------- ------------------------------
12. Date on which proxy holder will
cease to hold
voting rights:
--------------------------------------------- ------------------------------
13. Additional information: Figures are based on a total
number of voting rights of
124,999,993.
--------------------------------------------- ------------------------------
14. Contact name: Neil Whittaker, Aviva plc
--------------------------------------------- ------------------------------
15. Contact telephone number: 01603 684420
--------------------------------------------- ------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFESLRLEFIE
(END) Dow Jones Newswires
November 25, 2015 10:00 ET (15:00 GMT)
Aviva (LSE:AV.)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aviva (LSE:AV.)
Historical Stock Chart
From Apr 2023 to Apr 2024
